The Parkinson’s disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability

Erinc Hallacli(Brigham and Women's Hospital), Vikram Khurana(Broad Institute), Xiou H. Wang(Harvard University), D.R. Mani(Broad Institute), J. Timothy Greenamyre(University of Pittsburgh), Chad L. Myers(University of Minnesota), Namrata D. Udeshi(Broad Institute), Zoe Sheinkopf(Brigham and Women's Hospital), Steven A. Carr(Broad Institute), Aazam Vahdatshoar(Harvard University), Chee Yeun Chung(McLean Hospital), Sumaiya Nazeen(Brigham and Women's Hospital), Shubhangi Sathyakumar(Brigham and Women's Hospital), Matthew T. Keeney(Institute for Neurodegenerative Disorders), Xin Jiang(Tsinghua University), Roberto Di Maio(University of Pittsburgh), Philip L. De Jager(Broad Institute), Jackson Sandoe(Whitehead Institute for Biomedical Research), Xianjun Dong(Yale University), Shamil Sunyaev(European Molecular Biology Laboratory), Daniel Felsky(Centre for Addiction and Mental Health), Can Kayatekin(Whitehead Institute for Biomedical Research), David P. Bartel(Howard Hughes Medical Institute), Wen Wang(Northwestern Polytechnical University), Souvarish Sarkar(Iowa State University), Susan Lindquist(Howard Hughes Medical Institute), Mel Β. Feany(Brigham and Women's Hospital)
Cited by 167


Related Papers